Washington – A pediatric vaccine for respiratory syncytial virus (RSV),a highly contagious, common respiratory virus that infects the nose, throat, and lungs, is on hold, per US Food and Drug Administration`s instructions. An FDA document shows that a phase 1 trial of two experimental Moderna RSV vaccines in infants aged five to eight months was paused in July as five …
Ottawa – Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for individuals six months of age and older. Health Canada received Pfizer-BioNTech’s submission on June 29, 2023. After a thorough and independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, efficacy and quality requirements. …
Current recommendations An updated Covid-19 vaccine has been approved by Health Canada and will be available for use. Covid-19 vaccination reduces the risk of severe illness, death and post Covid-19 condition (long Covid). Starting in fall 2023, it’s recommended that you get an updated Covid-19 vaccine dose if it’s been at least 6 months: since your last Covid-19 vaccine dose …
Ottawa – Health Canada has authorized the use of the Moderna SPIKEVAX™ Covid-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. Health Canada received Moderna’s submission for its new Covid-19 vaccine on June 29, 2023. After a thorough, independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, …
